Due to a slip-up by the FDA, 600,000 bottles of Ramipril capsules are being recalled
over contamination concerns. The medication, used to treat hypertension and reduce
heart pressure after a heart attack, was manufactured by Lupin Pharmaceuticals in India,
where improper supplier checks were done. While the FDA believes the risk is low and
no adverse effects have been reported, it’s advised to dispose of bottles with sell-by dates
up to July 2026. The affected capsules come in 2.5 mg, 5 mg, and 10 mg strengths and are sold in bottles of 90, 10, or 150.
